Medical News

RSS

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.

3 Dec 2009

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Rules-Based Medicine, Inc. (RBM) today announced that Psynova Neurotech Limited (Cambridge UK), a majority-owned subsidiary of RBM, has executed an exclusive research and licensing agreement with Roche to collaborate on the discovery, development, validation and commercialization of diagnostic immunoassays to aid the clinical development and commercial differentiation of novel treatments for schizophrenia.

3 Dec 2009

ARC workers protest that unfair labor practices can endanger donor and blood safety issues

Teamsters who work at American Red Cross (ARC) Blood Services facilities in Philadelphia went on strike this morning to protest unfair labor practices and problems with working conditions at these facilities that could imperil the safety of donors and the integrity of the blood supply, not to mention the wellbeing of employees.

3 Dec 2009

Continued rise of PSA value in prostate cancer patients can indicate relapsing disease

Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related death, according to a study in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

3 Dec 2009

Tripep receives approval to extend ChronVac-C study

Today Tripep (STO:TPEP) received the approval from the Swedish Medical Products Agency and the local ethical committee to give three patients in the highest dose group in the ChronVac-C® study one additional treatment with the therapeutic vaccine.

3 Dec 2009

Survey reveals majority of Americans are not taking disability insurance

For most working-age Americans, their greatest asset is the ability to earn an income. It is this ability to earn an income that makes it possible to not only pay today's mortgage but also to plan and save for tomorrow's college and retirement costs.

3 Dec 2009

Experimentation may lead to permanent smoking habit among Mexican-American adolescents

Whether non-smoking Mexican-American adolescents go on to experiment with smoking depends largely on their initial attitude toward the habit, researchers at M. D. Anderson Cancer Center report in the December issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.

3 Dec 2009

Aditi Technologies, Microsoft BioIT Alliance sign agreement on Bioinformatics program

Aditi Technologies, a leading provider of software product and application development services, today announced its strategic partnership with Microsoft BioIT Alliance to extend its services focus into Bioinformatics.

3 Dec 2009

First Edition: December 3, 2009

Today's headlines indicate that Senate leaders may have broken their stalemate regarding the pending, Democratic-backed health reform legislation -- clearing the way today for votes on amendments.

3 Dec 2009

Most of the fatal falls in the home can be avoided with fall prevention and protection products

Healthcare costs are rapidly increasing due to the rapid aging of our population. The Center for Disease Control and Prevention indicates that over 60% of fatal falls occur in the home. Additionally, the total cost of falls in 2010 is expected to be between 68 and 100 Billion Dollars. More than 25,000 older adults died due to falls last year.

3 Dec 2009

Fruit flies are valid models for studying drug addiction in humans, says scientists

Fruit flies may seem like unlikely heroes in the battle against drug abuse, but new research suggests that these insects - already used to study dozens of human disease - could claim that role. Scientists are reporting that fruit flies can be used as a simpler and more convenient animal model for studying the effects of cocaine and other drugs of abuse on the brain.

3 Dec 2009

FAU professor highlights the need for extensive randomized trials to distinguish drug benefits

In a commentary published in the December 2, 2009 issue of the Journal of the American Medical Association, Charles H. Hennekens, M.D., the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science at Florida Atlantic University, said, "To detect the most likely small to moderate benefits or harm of drugs requires randomized trials of sufficient size and duration. Overreliance on small trials, meta-analyses or subgroup analyses can lead to misleading conclusions."

3 Dec 2009

Nonanesthesiologist-administered propofol for GI procedures safe

The worldwide safety experience of endoscopist-administered propofol sedation now exceeds 600,000 patients. The low rate of serious adverse events underscores the safety of nonanesthesiologist-administered propofol (NAAP) for gastrointestinal (GI) procedures, provided that it is administered by a team of individuals who have received training specific to the administration of propofol according to the "Position statement: nonanesthesiologist administration of propofol for GI endoscopy" issued by the four major gastroenterology and hepatology societies.

3 Dec 2009

Global HIV reporting and monitoring system provides good indication of overall progress towards HIV goal

Although much work remains to be done, a United Nations global reporting system on HIV/AIDS has already yielded an "unequaled wealth of data" on progress toward meeting UN targets for responding to the global HIV epidemic.

3 Dec 2009

Financial aspects of cancer treatment reduces compliance

New data being released today by the Association of Oncology Social Work (AOSW) demonstrate the extraordinary financial hardships that often complicate or compromise a patient’s battle against cancer. Sixty-three percent of oncology social workers surveyed said that financial issues reduce patients’ compliance with their cancer treatment – even though that treatment is key to their recovery. Forty percent of patients reported depleting their savings, while almost 30% reported dealing with bill collectors.

3 Dec 2009

One in six Americans expect to lose sleep due to holiday-induced stress

The kids may be sleeping soundly this season with “visions of sugar plums in their heads,” but almost half of the nation’s moms and dads (44%) say they are worried about being able to afford the holidays this year, with one in six Americans (17%) expecting to lose sleep due to holiday-induced stress.

3 Dec 2009

Distrust towards men does not prevent low-income women from entering into matrimony

Ninety-six percent of low-income mothers who participated in a recent study on gender-based distrust indicated a strong general feeling of distrust of the opposite sex. However, this general distrust towards men did not prevent them from entering into a marriage, live-in, or romantic relationship.

3 Dec 2009

China's SFDA initiates quality investigation of Simcere Pharmaceutical Group subsidiary's rabies vaccine

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").

3 Dec 2009

NOXXON Pharma achieves important milestone in drug discovery

NOXXON Pharma AG (NOXXON), the biopharmaceutical company focusing on the development of novel medicines based on its unique proprietary Spiegelmer® technology, announced today the achievement of an important milestone in its drug discovery and development partnership with Eli Lilly and Company.

3 Dec 2009

Airgas’ home-oxygen delivery system complies with new Medicare Accreditation rules

Airgas, Inc. (NYSE: ARG) today announced it has received clarification from the Center for Medicare and Medicaid Services that its long-standing delivery system for liquid oxygen and cylinders complies with the new Medicare Accreditation rules and the accreditation requirements of the new competitive bidding program for durable medical equipment (DME) providers.

3 Dec 2009

Medical News

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

ARC workers protest that unfair labor practices can endanger donor and blood safety issues

Continued rise of PSA value in prostate cancer patients can indicate relapsing disease

Tripep receives approval to extend ChronVac-C study

Survey reveals majority of Americans are not taking disability insurance

Experimentation may lead to permanent smoking habit among Mexican-American adolescents

Aditi Technologies, Microsoft BioIT Alliance sign agreement on Bioinformatics program

First Edition: December 3, 2009

Most of the fatal falls in the home can be avoided with fall prevention and protection products

Fruit flies are valid models for studying drug addiction in humans, says scientists

FAU professor highlights the need for extensive randomized trials to distinguish drug benefits

Nonanesthesiologist-administered propofol for GI procedures safe

Global HIV reporting and monitoring system provides good indication of overall progress towards HIV goal

Financial aspects of cancer treatment reduces compliance

One in six Americans expect to lose sleep due to holiday-induced stress

Distrust towards men does not prevent low-income women from entering into matrimony

China's SFDA initiates quality investigation of Simcere Pharmaceutical Group subsidiary's rabies vaccine

NOXXON Pharma achieves important milestone in drug discovery

Airgas’ home-oxygen delivery system complies with new Medicare Accreditation rules

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News